Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 - IMMUNE PHARMACEUTICALS INC | v434974_ex31-1.htm |
| 10-K - 10-K - IMMUNE PHARMACEUTICALS INC | v434974_10k.htm |
| EX-23.1 - EXHIBIT 23.1 - IMMUNE PHARMACEUTICALS INC | v434974_ex23-1.htm |
| EX-32.1 - EXHIBIT 32.1 - IMMUNE PHARMACEUTICALS INC | v434974_ex32-1.htm |
| EX-32.2 - EXHIBIT 32.2 - IMMUNE PHARMACEUTICALS INC | v434974_ex32-2.htm |
| EX-31.2 - EXHIBIT 31.2 - IMMUNE PHARMACEUTICALS INC | v434974_ex31-2.htm |
| EX-23.2 - EXHIBIT 23.2 - IMMUNE PHARMACEUTICALS INC | v434974_ex23-2.htm |
| EX-10.44 - EXHIBIT 10.44 - IMMUNE PHARMACEUTICALS INC | v434974_ex10-44.htm |
| EX-10.45 - EXHIBIT 10.45 - IMMUNE PHARMACEUTICALS INC | v434974_ex10-45.htm |
Exhibit 21.1
Subsidiaries of Immune Pharmaceuticals Inc.
The following are the subsidiaries of Immune Pharmaceuticals Inc.:
| Name | Jurisdiction of Incorporation | |
| Immune Pharmaceuticals USA Corp. | Delaware | |
| Immune Pharmaceuticals Ltd. | Israel | |
| Maxim Pharmaceuticals, Inc. | Delaware | |
| Cytovia, Inc. | Delaware | |
| EpiCept GmbH (closed January 2015) | Germany |